003060.KS
Aprogen Biologics Inc.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 1,380.00
−1.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.09x
- Price / sales
- 0.21x
- Price / cash flow
- -0.57x
Enterprise value
- Enterprise value
- KRW 283.5B
- EV / sales
- 3.29x
- EV / EBITDA
- -10.23x
- EV / EBIT
- -2.39x
- Market cap
- KRW 18.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026